Skip to content

Effectiveness and safety evaluation of dementia medical care using online medical care

Effectiveness and safety evaluation of online dementia medical care - Effectiveness and safety evaluation of online dementia medical care

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040890
Enrollment
24
Registered
2020-06-25
Start date
2020-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia

Interventions

Face-to-face consultation period online medical treatment combination period

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who visit our memory clinic. Patients with dementia or mild cognitive impairment between the ages of 50 and under 95. Person who can determine that necessary inspection can be performed on the specified date after obtaining consent Study partners have at least 7 hours of contact with the subject per week and can accompany all consultations during the observation period. Person who obtained consent in writing from the research participant and study partner Person who can use online medical care.

Exclusion criteria

Exclusion criteria: Person with a history of substance use disorder other than smoking or being treated Person who has a history of epilepsy or is being treated Persons receiving antidepressants, antipsychotics, hypnotics including long-term sleeping pills Persons with a history of psychiatric/neurological disorders that affect cognitive function Persons with serious complications

Design outcomes

Primary

MeasureTime frame
The main endpoints in this study are measured at the start of the study (0 weeks), 24 weeks, and 48 weeks by the three-time evaluation Zarit care burden scale.

Secondary

MeasureTime frame
Cognitive function(MMSE), clinical dementia rating(CDR), questionnaire version Neuropsychiatric Inventory-Brief Questionnaire Form (NPI-Q), Geriatric depression scale 15 (GDS15) at the start of the study (0weeks), 24 weeks, 48weeks 3evaluations.

Countries

Japan

Contacts

Public ContactDaisuke Ito

Keio University School of Medicine Department of Neurology

dito@keio.jp0353633788

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026